No. Phase 2 is primarily to establish safety and dosage. Phase 3 is primarily to establish efficacy. This is the US National Institutes of Health description of the 4 clinical trial phases:
http://www.nlm.nih.gov/services/ctphases.html
- Forums
- ASX - By Stock
- ATH
- ITM....partial hold IMO
ITM....partial hold IMO, page-6
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $1.447K | 368K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 52624257 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 127090587 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 52624257 | 0.003 |
60 | 89908098 | 0.002 |
27 | 122861099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 127090587 | 26 |
0.005 | 32268732 | 28 |
0.006 | 13948927 | 18 |
0.007 | 47851651 | 23 |
0.008 | 22758132 | 24 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |